VANGUARD GROUP INC 13D and 13G filings for Karuna Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-13 5:08 pm Purchase | 2023-12-29 | 13G | KARUNA THERAPEUTICS INC KRTX | VANGUARD GROUP INC | 3,224,786 8.550% | 471,243 (+17.11%) | Filing |
| 2023-02-09 11:25 am Purchase | 2022-12-30 | 13G | KARUNA THERAPEUTICS INC KRTX | VANGUARD GROUP INC | 2,753,543 8.010% | 669,207 (+32.11%) | Filing |
| 2022-02-10 08:22 am Purchase | 2021-12-31 | 13G | KARUNA THERAPEUTICS INC KRTX | VANGUARD GROUP INC | 2,084,336 7.040% | 2,084,336 (New Position) | Filing |